LeJeune Puetz Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$107K	Hold	830	–	–	0.04%	193
2022 Q4	$109K	Buy	+830	New	+$107K	0.04%	189
2022 Q2	–	Sell	-830	Closed	-$108K	–	192
2022 Q1	$108K	Hold	830	–	–	0.04%	188
2021 Q4	$127K	Hold	830	–	–	0.04%	185
2021 Q3	$134K	Hold	830	–	–	0.05%	180
2021 Q2	$136K	Hold	830	–	–	0.05%	178
2021 Q1	$125K	Hold	830	–	–	0.05%	180
2020 Q4	$126K	Hold	830	–	–	0.05%	176
2020 Q3	$112K	Hold	830	–	–	0.05%	170
2020 Q2	$113K	Buy	+830	New	+$106K	0.06%	161
2020 Q1	–	Sell	-980	Closed	-$118K	–	177
2019 Q4	$118K	Buy	+980	New	+$109K	0.06%	173
2019 Q3	–	Sell	-980	Closed	-$107K	–	181
2019 Q2	$107K	Buy	+980	New	+$104K	0.06%	175

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LeJeune Puetz Investment Counsel's IBB Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel held its iShares Biotechnology ETF (IBB) position steady in Q1 2023 at 830 shares worth $107K. The position accounts for 0.04% of the portfolio, ranked #193.

LeJeune Puetz Investment Counsel first reported a position in IBB in Q2 2019 and has held it in 12 quarters since. The position peaked at $136K in Q2 2021. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

LeJeune Puetz Investment Counsel held 830 shares of iShares Biotechnology ETF worth $107K as of Q1 2023.
LeJeune Puetz Investment Counsel left its iShares Biotechnology ETF share count unchanged in Q1 2023.
iShares Biotechnology ETF made up 0.04% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #193 holding.
LeJeune Puetz Investment Counsel first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 12 quarters since.
LeJeune Puetz Investment Counsel's iShares Biotechnology ETF position peaked at $136K in Q2 2021.
867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.